EGFR-TKI ADR Management Chinese Expert Consensus
Chinese Journal of Lung Cancer, 2019 ErbB receptor tyrosine kinase inhibitors (EGFR-TKI), gefitinib, erlotinib, icotinib and aftinib, which are approved as a frontline treatment for patients with non-small cell lung cancer (NSCLC) who have tumors harboring EGFR mutations in China.
Chinese Society of Lung Cancer, Chinese Anti-Cancer Association
doaj +2 more sources
China Anti-Cancer Association guideline for diagnosis and treatment of cancer of multiple and unknown primaries (2023 edition) [PDF]
Zhongguo aizheng zazhi, 2023 Cancer of unknown primary (CUP) and cancer of multiple primaries (CMP) are two groups of neoplasm with high heterogeneity, low incidence, limited clinical knowledge and evidence.
Society of Cancer of Multiple and Unknown Primary of China Anti-Cancer Association Yuguang
doaj +2 more sources
Chinese expert consensus on whole-process management of oxaliplatin-induced hypersensitivity reactions (2024 edition) [PDF]
Zhongguo aizheng zazhiOxaliplatin serves as a basic therapeutic agent for various malignant tumors. Oxaliplatin-induced hypersensitivity reactions are potentially life-threatening, and frequently lead to treatment discontinuation.
Cancer Assessment Society of China Anti-Cancer Association, Cancer Pain Society of Fujian Anti-Cancer Association
doaj +1 more source
Shanghai plan for early screening, diagnosis and treatment of colorectal cancer (2023 edition) [PDF]
Zhongguo aizheng zazhiColorectal cancer is a common malignant tumor in China. At present, the incidence rate and the mortality rate of colorectal cancer in China are on the rise.
Colorectal Cancer Special Committee of Shanghai Anti-Cancer Association
doaj +3 more sources
Cell & Bioscience, 2012 A novel, cancer-fighting function was recently discovered for Smad ubiquitination regulatory factor 2 (Smurf2).
Zhao Keji, Shi Yun-Bo
openaire +3 more sources
Emerging data supporting stromal cell therapeutic potential in cancer: reprogramming stromal cells of the tumor microenvironment for anti-cancer effects [PDF]
, 2020 After more than a decade of controversy on the role of stromal cells in the tumor microenvironment, the emerging data shed light on pro-tumorigenic and potential anti-cancer factors, as well as on the roots of the discrepancies.
Simo, Richard Tagne +11 more
core +1 more source
Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer (2024 edition) [PDF]
Zhongguo aizheng zazhiIn China, 60% of breast cancer patients were premenopausal women at the time of diagnosis. Compared with postmenopausal women, premenopausal women have strong ovarian function and secrete estrogen to promote breast cancer growth.
China Anti-Cancer Association Committee of Breast Cancer Society,
doaj +2 more sources
A prelude report on molecular docking of HER2 protein towards comprehending anti-cancer properties of saponins from Solanum tuberosum [PDF]
, 2012 Saponins are extensively known for many biological activities e.g. antimicrobial, anti-palatability, anti-cancer and hemolytic. As cancer cells have a more cholesterol-like compound in their membrane structure the saponins bind cholesterol due to their ...
Puneet K. Singh, Pratyoosh Shukla
core +1 more source
Expert consensus on perioperative comprehensive treatment for high risk prostate cancer (2023 edition) [PDF]
Zhongguo aizheng zazhi, 2023 The incidence rate of prostate cancer is showing an upward trend year by year, gradually becoming an important disease affecting the health of middle-aged and elderly men.
of Male Reproductive System Oncology Society +1 more
doaj +2 more sources
Revealing the Potency of Cinnamon as an Anti-cancer and Chemopreventive Agent [PDF]
, 2018 Cinnamon (Cinnamomum spp.), an ancient spice, has been explored as a potential for medicinal purposes. Despite numerous studies about its potency in overcoming of numerous diseases, the potency as anti-cancer would be a challenge.
Yonika Arum Larasati +3 more
core +1 more source